MODIFIED CELLS AND METHODS OF THERAPY Read more about MODIFIED CELLS AND METHODS OF THERAPY US Application 62/360,245Filed on 2016-07-08
INTRACELLULAR GENOMIC TRANSPLANT AND METHODS OF THERAPY Read more about INTRACELLULAR GENOMIC TRANSPLANT AND METHODS OF THERAPY US Application 62/330,464Filed on 2016-05-02
GENETICALLY MODIFIED CELLS AND METHODS OF USE Read more about GENETICALLY MODIFIED CELLS AND METHODS OF USE US Application 62/295,970Filed on 2018-02-16
NON-VIRAL MODIFIED CELLS AND METHODS OF THERAPY Read more about NON-VIRAL MODIFIED CELLS AND METHODS OF THERAPY US Application 62/286,206Filed on 2016-01-22
NON-VIRAL MODIFIED CELLS AND METHODS OF THERAPY Read more about NON-VIRAL MODIFIED CELLS AND METHODS OF THERAPY US Application 62/232,983Filed on 2015-09-25
NON-VIRAL TCR MODIFIED CELLS AND METHODS OF THERAPY Read more about NON-VIRAL TCR MODIFIED CELLS AND METHODS OF THERAPY US Application 62/199,905Filed on 2015-07-31
AFFINITY MATURED CD22-SPECIFIC MONOCLONAL ANTIBODY AND USES THEREOF Read more about AFFINITY MATURED CD22-SPECIFIC MONOCLONAL ANTIBODY AND USES THEREOF US Application 62/697,185Filed on 2018-07-12
Compositions and Methods for Treating Cancer with Anti-CD38 Immunotherapy Read more about Compositions and Methods for Treating Cancer with Anti-CD38 Immunotherapy US Application 62/773,940Filed on 2018-11-30
ANTI-SLAMF7 CHIMERIC ANTIGEN RECEPTORS Read more about ANTI-SLAMF7 CHIMERIC ANTIGEN RECEPTORS US Application 62/693,779Filed on 2018-07-03
Glypican 2 As A Cancer Marker And Therapeutic Target Read more about Glypican 2 As A Cancer Marker And Therapeutic Target US Application 62/350,976Filed on 2016-06-16